Publication:
[Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations].

dc.contributor.authorÁlvarez García, Francisco José
dc.contributor.authorCilleruelo Ortega, María José
dc.contributor.authorÁlvarez Aldeán, Javier
dc.contributor.authorGarcés-Sánchez, María
dc.contributor.authorGarcía Sánchez, Nuria
dc.contributor.authorGarrote Llanos, Elisa
dc.contributor.authorHernández Merino, Ángel
dc.contributor.authorIofrío de Arce, Antonio
dc.contributor.authorMontesdeoca Melián, Abián
dc.contributor.authorNavarro Gómez, María Luisa
dc.contributor.authorRuiz-Contreras, Jesús
dc.contributor.authoren representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP)
dc.date.accessioned2023-02-09T10:39:25Z
dc.date.available2023-02-09T10:39:25Z
dc.date.issued2021
dc.description.abstractThe CAV-AEP annually publishes the immunisation schedule considered optimal for all children and adolescent resident in Spain, taking into account the available evidence. The 2+1 schedule is recommended (2, 4, and 11 months) with hexavalent vaccines (DTPa-VPI-Hib-HB) and with 13-valent pneumococcal conjugate.A 6-year booster is recommended, preferably with DTPa (if available), with a dose of polio for those who received 2+1 schemes, as well as vaccination with Tdpa in adolescents and in each pregnancy, preferably between 27 and 32 weeks. Rotavirus vaccine should be systematic for all infants. Meningococcal B vaccine, with a 2+1 schedule, should be included in routine calendar. In addition to the inclusion of the conjugated tetravalent meningococcal vaccine (MenACWY) at 12 years of age with catch up to 18 years, inclusive, the CAV recommends this vaccine to be also included at 12 months of age, replacing MenC. Likewise, it is recommended in those over 6 weeks of age with risk factors or who travel to countries with a high incidence of these serogroups. Two-dose schedules for triple viral (12 months and 3-4 years) and varicella (15 months and 3-4 years) will be used. The second dose could be applied as a tetraviral vaccine. Universal systematic vaccination against HPV is recommended, regardless of gender, preferably at 12 years, and greater effort should be made to improve coverage. The 9 genotype extends coverage for both genders.
dc.identifier.doi10.1016/j.anpedi.2020.10.002
dc.identifier.essn2341-2879
dc.identifier.pmid33419517
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.anpedi.2020.10.002
dc.identifier.urihttp://hdl.handle.net/10668/16943
dc.issue.number1
dc.journal.titleAnales de pediatria
dc.journal.titleabbreviationAn Pediatr (Engl Ed)
dc.language.isoes
dc.organizationHospital Costa del Sol
dc.page.number53.e1-53.e10
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdolescent
dc.subjectAdolescente
dc.subjectCalendario de vacunación
dc.subjectChild
dc.subjectEnfermedades inmunoprevenibles
dc.subjectImmunisation schedule
dc.subjectInfant
dc.subjectLactante
dc.subjectNiño
dc.subjectVaccine preventable diseases
dc.subjectVaccines
dc.subjectVacunas
dc.subject.meshAdolescent
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunization Schedule
dc.subject.meshInfant
dc.subject.meshMale
dc.subject.meshSpain
dc.subject.meshVaccination
dc.subject.meshVaccines, Combined
dc.title[Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations].
dc.title.alternativeCalendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2021.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number94
dspace.entity.typePublication

Files